about
The Smart Drug Delivery System and Its Clinical PotentialLoss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor αHigh-intensity focused ultrasound provides palliation for liver metastasis causing gastric outlet obstruction: case report.Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report.Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sightOral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.Tissue polypeptide antigen & interleukin-6: Are their serum levels a predictor for response to chemotherapy in breast cancer?Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients.Headway in resistance to endocrine therapy in breast cancer.Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic ModificationPersonalized medicine and the clinical laboratory.Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus.A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.Prognostic factors in 1,038 women with metastatic breast cancer.Sequential Metastatic Breast Cancer Chemotherapy: Should the Median be the Message?Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia.Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasisAssessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience.Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer.Managing anxiety and depression during treatment.Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin.PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.Physiologically based pharmacokinetic model of docetaxel and interspecies scaling: comparison of simple injection with folate receptor-targeting amphiphilic copolymer-modified liposomes.Evaluation of chemotherapeutics in a three-dimensional breast cancer model.Lapatinib: an oral dual tyrosine kinase inhibitor for HER-2-positive breast cancer.Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.Genetic polymorphisms and metastatic breast cancer survival.Slingshot-1L, a cofilin phosphatase, induces primary breast cancer metastasis.Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer.
P2860
Q26744837-9CB24312-D67D-4F06-8BBF-1C37AC2A43ECQ28308069-AAFDC2B9-DF94-4FB2-ACF8-4DEC13C796A6Q30422897-F47CF9E0-5BEC-4CB1-8445-C4A9D7D6BCD5Q30978860-72ABF9EB-39C7-413A-9B6B-316DD9CB87E9Q33591140-EA2F1B55-BD18-4E68-8B9E-F90FD370842CQ33895102-0F0C27D9-9F6E-493E-8DD0-DCC8C601306DQ34010413-101E900D-7546-41C4-84A1-68EC30D1096FQ34103876-A9D953FD-6038-42DB-B7BB-50A45CA77588Q34176287-55FE0D5C-0689-43AB-8E5E-EDD09DC4958EQ34912378-005E65AA-2229-474F-AF7E-88B8CE537102Q34993796-32269733-F6D3-483D-950D-E3892DC77B5EQ35667708-75957BD2-EF02-4517-9840-5669198B8EF1Q35879834-CB4D7EF9-6968-4A59-B0D8-6AB5E0A05623Q35927834-10E59FAB-3B75-4973-B58F-090164CD521CQ36180432-A44B5ABB-C69E-4B55-926D-D3F2E0FB37BEQ36916966-FD225B8F-255C-4FC4-B307-A043B547C810Q36928622-849E55B2-0341-4756-B9ED-B36740928C0DQ37160641-AB9535A3-F56D-43A8-9C1D-EA35F4D73F5FQ37321930-5C39667B-2500-4A62-9D6B-8D568237B3D5Q37385471-203AE7B3-9CCC-4D94-8205-386E92AFCBC2Q37409301-8FA688B9-3039-4445-9686-4B2D48D9DE1CQ37456497-CB604950-63BC-40AA-95DA-93888FB9D5F2Q37529876-2737176E-C9DB-4CF9-8E02-86445A98781CQ37601851-C13B75F9-D5EE-4445-AF46-577E11AF50CFQ37700409-7ADC5349-4DF6-4C49-A75D-9497A24BDE30Q38265916-64E46758-1866-4D59-AA66-42F445760529Q38726651-E655D3E3-B261-4482-95C7-B77B1EC0A3D4Q38810389-B8957965-57BA-4843-A04A-0369DDAC0B65Q38889788-3D12EF5A-D37D-47C6-AC6E-95D074F8CCD7Q38893881-83E37734-A445-4044-8344-0B72863134BCQ38899711-A24C1010-5219-4F2D-8983-5F147F1450A1Q38992588-06DA6C36-199B-4EAE-A1F5-BC4DD9536172Q39115827-5D1606E4-9D43-4DDC-A9BF-F5B6F6DDD5C7Q39375100-36614EF5-CE1D-4C88-B0F9-E96D1F4BF8CDQ39511638-75A26D5B-03AF-4C46-83C2-E3DBF8CA944AQ39720714-D5B8F21D-334A-4B9F-B7F0-7234D999E9DAQ40230805-51AEE062-9A41-4E78-946D-DFA94FB59942Q42371620-734E07C8-86F0-4099-84C8-9E8C6FAF55BEQ43543688-3F00C289-7F89-47B3-B4BA-D74973D01C5AQ47123679-D153ED52-4813-40E4-8433-B59BA142C9EE
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Metastatic breast cancer: an updating.
@ast
Metastatic breast cancer: an updating.
@en
type
label
Metastatic breast cancer: an updating.
@ast
Metastatic breast cancer: an updating.
@en
prefLabel
Metastatic breast cancer: an updating.
@ast
Metastatic breast cancer: an updating.
@en
P2093
P50
P1476
Metastatic breast cancer: an updating.
@en
P2093
R Giardino
S Colosimo
P304
P356
10.1016/J.BIOPHA.2006.07.086
P577
2006-08-28T00:00:00Z